AHA Urges USP to Delay Effective Dates for New Guidelines

AHA today urged the United States Pharmacopeial Convention to delay by at least 18 months the effective dates for its general chapter <797> pharmaceutical compounding and general chapter <800> hazardous drug handling in health care settings, as well as proposed revisions to general chapter <797>. “USP guidelines play a critical role in keeping our hospital staffs and the patients they care for safe,” AHA wrote. “However, we reiterate concerns we have previously shared regarding the compliance challenges that these two sections create.” Specifically, the proposed changes to general chapter <797> may impact or modify efforts by hospitals and health systems to comply with chapter <800>; the guidelines involve large capital investments, in some cases the construction of entirely new buildings; and the timeline has resulted in high demand for contractors and supplies, making it very challenging for all facilities to comply by the effective date, AHA said. The association also commended USP for simplifying many provisions in its September redraft of general chapter <797>, but shared some concerns regarding the beyond-use dates, repackaging and temperature metrics.

Related Resources

Amicus Brief
Amici Curiae Brief of the North Dakota Medical Association, North Dakota Hospital Association, American Hospital Association and American Medical A
Download the letter (PDF) below Re: CMS—3346—P, Medicare
Case Studies
Violence is a significant public health issue and of great concern to hospitals caring for victims of violence.
Webinar Recordings
This Webinar was Held November 9 at 2PM CST The proliferation of disruptors in healthcare coupled with the desire to connect
Legal Documents
Memorandum Opinion This case is now before the Court for a third ti
On Sept. 20, the Centers for Medicare…